DIVI'S LABORATORIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,931 INR | +0.99% |
|
+3.73% | +0.70% |
| Apr. 26 | Weak March Quarter Earnings Weigh Down Indian Equities on Friday | MT |
| Apr. 25 | Divi's Laboratories Plans Up To INR7 Billion Investment to Boost Capacity | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.38B | ||||||
| 709B | ||||||
| 595B | ||||||
| 367B | ||||||
| 334B | ||||||
| 289B |
